Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence

Clin Chim Acta. 2024 Apr 23:119686. doi: 10.1016/j.cca.2024.119686. Online ahead of print.ABSTRACTColorectal cancer (CRC) is a leading cause of cancer-related deaths. Recent advancements in genomic technologies and analytical approaches have revolutionized CRC research, enabling precision medicine. This review highlights the integration of multi-omics, spatial omics, and artificial intelligence (AI) in advancing precision medicine for CRC. Multi-omics approaches have uncovered molecular mechanisms driving CRC progression, while spatial omics have provided insights into the spatial heterogeneity of gene expression in CRC tissues. AI techniques have been utilized to analyze complex datasets, identify new treatment targets, and enhance diagnosis and prognosis. Despite the tumor's heterogeneity and genetic and epigenetic complexity, the fusion of multi-omics, spatial omics, and AI shows the potential to overcome these challenges and advance precision medicine in CRC. The future lies in integrating these technologies to provide deeper insights and enable personalized therapies for CRC patients.PMID:38663471 | DOI:10.1016/j.cca.2024.119686
Source: International Journal of Clinical Chemistry - Category: Chemistry Authors: Source Type: research